Key result
Catheter ablation for atrial fibrillation in patients with prior ischemic stroke resulted in similar rates of AF recurrence compared to patients without prior stroke.
Why the study?
Does catheter ablation of atrial fibrillation have similar efficacy and safety in patients with prior ischemic stroke compared to those without?
Cohort (n=1,768)
No
Does catheter ablation of atrial fibrillation have similar efficacy and safety in patients with prior ischemic stroke compared to those without?
Catheter ablation for atrial fibrillation is feasible and has similar rates of AF recurrence and stroke in patients with a prior ischemic stroke compared to those without.
Answers are grounded in this paper and cite their sources.
May support ablation consideration in AF with prior stroke; hypothesis-generating pending randomized confirmation.
BACKGROUND: Catheter ablation for atrial fibrillation (AF) has been demonstrated to be effective in a subsets of patients with AF. However, very few data are available in regard to patients with prior history of stroke undergoing catheter ablation. This study aimed to investigate the outcome of catheter ablation in AF patients with prior ischemic stroke. METHODS: Between January 2008 and December 2011, of 1897 consecutive patients who presented at Beijing An Zhen Hospital for treatment of drug-refractory AF, 172 (9.1%) patients in the study population had a history of ischemic stroke. All patients underwent catheter ablation and were followed up to assess maintenance of sinus rhythm and recurrence of symptomatic stroke. RESULTS: Among these 1897 patients, 1768 (93.2%) who had complete follow-up information for a minimum of six months were included in the final analysis. Patients in the stroke group (group I) and the no-stroke group (group II) were similar in regards to gender, body mass index (BMI), history of diabetes, type of AF, and left atrial size. The patients in group I were older than those in group II, and had a higher incidence of hypertension, chronic heart failure, lower left ventricular ejection fraction (LVEF), and higher CHADS2 scores. Six months after ablation, 107 (68.6%) patients in group I and 1403 (87.1%) in group II had discontinued warfarin treatment (P < 0.001). During a median follow-up of (633 ± 415) days, 65 patients in the group I and 638 in group II experienced AF recurrence, and five patients in group I and 28 in group II developed symptomatic stroke. The rates of AF recurrence and recurrent stroke were similar between group I and group II (41.7% vs. 39.6%, P = 0.611; 3.2% vs. 1.7%, P = 0.219; respectively). CONCLUSION: Catheter ablation of AF in patients with prior stroke is feasible and efficient.
No takes yet. Share an insight, caveat, or question.
Li et al. (2013) conducted a cohort in Atrial fibrillation (n=1,768). Catheter ablation vs. Patients without prior ischemic stroke was evaluated on Atrial fibrillation recurrence (p=0.611). Catheter ablation for atrial fibrillation in patients with prior ischemic stroke resulted in similar rates of AF recurrence compared to patients without prior stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: